Rockrose continue strong start to 2020 with Cotton gas field acquisition
Mattioli Woods report strong half year as revenue rises 3.8%
Mattioli remain confident
The firm has delivered some impressive results over the last few months, and the sentiment was made aware in the comments from the CEO as he continued: “We believe the benefits of operating a responsibly integrated business allows us to secure great client outcomes including controlling clients’ costs whilst delivering strong, sustainable shareholder returns over the long term. The Board remains committed to growing the dividend, while maintaining an appropriate level of dividend cover. Accordingly, the Board is pleased to recommend the payment of an increased interim dividend, up 15.3% to 7.3p per share (1H19: 6.33p). “In addition to the positive contribution from recent acquisitions, the Group generated an increased share of profit from Amati of £0.3m (1H19: £0.2m), whose total funds under management had increased to £510.2m (31 May 2019: £452.8m) at the period end. “In December 2019, we were pleased to follow the Broughtons and SSAS Solutions transactions with the acquisition of The Turris Partnership Limited, which provides chartered financial planning and wealth management advice and has over £65m of client assets under advice. “Clients need long-term advice and strategies more than ever before. More than a decade of low interest rates and evolving client preferences, including environmental, social and governance considerations, have created challenges for people seeking to generate income, while preserving and growing their capital. While we anticipate greater client activity and increasing inflows into our bespoke investment services following the UK General Election result in December 2019, there remains some uncertainty around the exact shape of Brexit. “We will continue to provide quality solutions, maintaining our focus on client service and continuing to adapt our business model to the changing market, integrating asset management and financial planning to build upon our established reputation for delivering sound advice and consistent investment performance, while looking to reduce clients’ costs. “We plan to build on the progress achieved in the first half of this financial year, advancing our strategic initiatives, such as the development of new products and services and our own IT solutions where possible. Our profit outlook for the year remains in line with management’s expectations and we believe the Group is well-positioned to grow, both organically and by acquisition, to continue delivering sustainable shareholder returns.” Shares in Mattioli Woods trade at 860p (+2.38%). 4/2/20 13:16BST.DWF says PMI rebound not enough to rebuild deflated construction sector
Speaking on the results, Kate Kirby of DWF stated:
“Like the manufacturing sector, construction is highly reliant on economic certainty and, as we all know, that was been in short supply throughout 2019. However, the start to 2020 looks a little better. There was some sign of improvement, in that the slowdown in the construction sector eased to its slowest pace in eight months in January but the fact that the two largest contributions to the fall in output came from civil engineering and commercial construction is troubling.”
“The latest construction PMI data is unlikely to provide any real comfort. Though this rebound is a welcome sign, the danger remains the sector could shrink again. The political situation in the UK and its attempt to navigate through trade deals this year could see construction businesses experiencing a see-saw of good and bad news in the coming months.”
Coronavirus will be around for “months” warns UK Health Secretary
Hong Kong have reported their first coronavirus death on Tuesday, as the country has been hit with a global health worry about the potency of the lethal disease.
Hong Kong became the second mainland that has reported a death, which has killed 427 people as the numbers rise vastly.
Only a few days back, I was sitting in this same spot writing about the coronavirus death toll reaching 81 but looking now at the 427 figure, this has not just become a case of a global health disaster but also a global economic disaster.
Chinese markets have leveled toady after it was reported yesterday that almost $400 billion was wiped off stock and business values yesterday, but the bad new has far from stopped.
It was interesting to see that Hyundai Motor (KRX:005380) said today that they were planning to suspend operations in South Korea due to the risk of the coronavirus disrupting supply chains.
Hyundai became the first automobile manufacturer to stop production outside of China, and the economic impact of the virus continues to weigh down on the global economy.
“Hyundai and Kia may be more affected as they tend to import more parts from China than other global automakers,” said Lee Hang-koo, senior researcher at the Korea Institute for Industrial Economics & Trade.
“South Korean parts makers followed and built their own facilities along with Hyundai,” Lee said.
The health secretary Matt Hancock has warned the British public that the coronavirus “will be with us for at least some months to come”, as growing concerns of British people rise over potential cases of the lethal disease spreading to the UK.
He told the House of Commons that the number of new cases worldwide was “doubling every five days” and dealing with it was “a marathon, not a sprint”.
These are testing times for global governments, however as Hancock said this could be something which is dealt with over a period of months, and an instant resolution may not be available.
Uniphar remain confident to deliver growth across 2020
Uniphar PLC (LON:UPR) have said on Tuesday that they are confident to deliver growth in 2020, following a strong performance in the recent year of trading.
The firm, who works in providing healthcare services said that it has performed well in 2019, following organic gross profit growth of 7% as earnings before interest, tax, depreciation and amortisation remained in line with forecasts.
The firm said that it is continuing to build on its growth strategy to meet the needs of speciality manufacturers through the provision of higher value services.
For 2020, the firm said “Looking forward into 2020, Uniphar is well positioned to deliver continued organic growth across all divisions, in line with its medium-term outlook, with the additional benefit of the full year impact of recent bolt-on acquisitions.”
Ger Rabbette, Group Chief Executive commented:
“Our trading update reflects a strong performance for 2019 in line with Group expectations and positions us to deliver our plan for 2020 consistent with our medium term outlook. We are delivering on our committed strategy in our growth divisions being:
1. Growing a pan European platform in Commercial & Clinical where we are now present in the Nordics as well as Ireland, UK and the Benelux; and
2. Developing a global platform in our Product Access division which is now in place following the acquisition of Durbin
Our Product Access and Commercial & Clinical divisions continue to be the key growth engines for the Group particularly in the UK, Benelux and Nordics markets while Supply Chain & Retail saw strong volume and gross profit growth in Ireland.
We are well positioned going into 2020 for the next stage of our planned development in delivering our five-year strategy of doubling EBITDA. Additionally, we look forward to declaring a dividend for our shareholders.”
Uniphar’s two new acquisitions
In November, Uniphar said that they had acquired two new firms as part of their growth and development strategy.
The two names acquired were Nordic based EPS Group and Irish firm M3 Medical.
The total potential cost for EPS Group and M3 medical will be approximately €40 million, and they payment will be spread over four years.
The deal will be financed from the funds raised from the initial public offering in July, and coupled with a combined placing shortly after was valued at €139 million.
On a pro-forma basis, for 2019, these acquisitions in aggregate are expected to deliver revenue of about €22 million.
Both the EPS Group and M3 Medical will be integrated into the Commercial & Clinical Medtech division of Uniphar.
Shares in Uniphar trade at €1 (-1.17%). 4/2/20 12:36BST.
